Photobiomodulation as a treatment tool in a domestic cat with multiple comorbidities – case report
Abstract
The use of phototherapy techniques involving Low-Level Laser Therapy (LLLT) has gained increasing ground in small animal veterinary practice. Among the phototherapy techniques applied in veterinary medicine, transdermal systemic vascular irradiation—which involves irradiating the blood circulating within the animal's body—is a treatment of choice for animals with multiple comorbidities; it can act as a complement to conventional therapeutic protocols or be used independently (Pryor & Millis, 2015; Mendes & Arias, 2012). Given this context, the objective of this case report is to demonstrate the effectiveness of transdermal systemic vascular irradiation phototherapy in treating a domestic cat with multiple comorbidities. For phototherapy treatment, a (GaAlAr) laser diode was used with the following parameters: wavelength (λ) of 658 nm, power (P) of 180 mW, spot area (Ø) of 0.0125 cm², energy density (DE) of 6,912 J/cm², and energy (J) of 86.4 J. In this case report, the use of transdermal systemic vascular phototherapy in a feline patient effectively and lastingly modulated chronic degenerative processes and controlled pain caused by spinal spondylosis. Significantly, it improved the patient's quality of life, enabling the animal to explore other areas of its living environment and exhibit species-specific behaviors.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.